Author:
Conte P. F.,Pronzato P.,Falcone A.,Gardin G.,Lionetto R.,Rubagotti A.,Tuvo I.,Rosso R.,Di Marco E.,Alama A.,Nicolin A.,Gentilini P.,Amadori D.,Sussio M.,Sismondi P.,De Micheli R.,Garnino F.,Monzeglio C.,Jacomuzzi A.,Mossetti C.,Gallotti P.
Reference7 articles.
1. Perlow, L.S. and Holland, J.F. (1984) Chemotherapy of breast cancer. Med. Oncol. & Tumor Pharmacother. 1:149.
2. Lippman, M.E. (1983) Efforts to combine endocrine and chemotherapy in the management of breast cancer: Do two and two equal three? Breast Cancer Res. Treat. 3:117.
3. Lippman, M., Bolan, G. and Huff, K. (1976) The effects of estrogens and antiestrogens on hormone-responsive human breast cancer in long term tissue culture. Cancer Res. 36:4595.
4. Conte, P.F., Alama, A., Nicolin, A., Corsaro, E., Canavese, G., Rosso, R., Fraschini, G. and Drewinko, B. (1985) Chemotherapy estrogen induced expansion of the growth fraction of human breast cancer. Cancer Res. 45:5926.
5. Allegra, J.C. (1983) Methotrexate and 5-Fluorouracil following tamoxifen and premarin in advanced breast cancer. Seminars in Oncology 10 (2); 23.